Arkolith/Insider Trading/ANEB/Form 4

22NW, LP

10% OwnerAnebulo Pharmaceuticals, Inc. (ANEB) · full profile →Form 4 · filed Dec 20, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 18, 2023Gift(G)300K—$00
Dec 18, 2023Gift(G)300K—$05.4M
Nov 13, 2023Grant(A)300K—$0300K

Transaction Codes

G
Gift
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-059337) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML